References
- Stewart BW, Bray F, Forman D, Ohgaki H, Straif K, Ullrich A, Wild CP . Cancer prevention as part of precision medicine: ‘plenty to be done’. Carcinogenesis. 2016;37(1):2–9. doi:https://doi.org/10.1093/carcin/bgv166
- Tyrovolas S, Panagiotakos DB. The role of Mediterranean type of diet on the development of cancer and cardiovascular disease, in the elderly: a systematic review. Maturitas. 2010;65(2):122–30. doi:https://doi.org/10.1016/j.maturitas.2009.07.003
- Sweeney CJ, Chen Y-H, Carducci M, Liu G, Jarrard DF, Eisenberger M, Wong Y-N, Hahn N, Kohli M, Cooney MM, et al. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med. 2015;373(8):737–46. doi:https://doi.org/10.1056/NEJMoa1503747
- Fizazi K, Tran N, Fein L, Matsubara N, Rodriguez-Antolin A, Alekseev BY, Özgüroğlu M, Ye D, Feyerabend S, Protheroe A, et al. Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer. N Engl J Med. 2017;377(4):352–60. doi:https://doi.org/10.1056/NEJMoa1704174
- Freedland SJ, Allen J, Jarman A, Oyekunle T, Armstrong AJ, Moul JW, Sandler HM, Posadas E, Levin D, Wiggins E, et al. A randomized controlled trial of a 6-month low-carbohydrate intervention on disease progression in men with recurrent prostate cancer: carbohydrate and Prostate Study 2 (CAPS2). Clin Cancer Res. 2020;26(12):3035–43. doi:https://doi.org/10.1158/1078-0432.CCR-19-3873
- Paoli A, Bianco A, Damiani E, Bosco G. Ketogenic diet in neuromuscular and neurodegenerative diseases. Biomed Res Int. 2014;2014:474296. doi:https://doi.org/10.1155/2014/474296
- Allen BG, Bhatia SK, Anderson CM, Eichenberger-Gilmore JM, Sibenaller ZA, Mapuskar KA, Schoenfeld JD, Buatti JM, Spitz DR, Fath MA, et al. Ketogenic diets as an adjuvant cancer therapy: history and potential mechanism. Redox Biol. 2014;2:963–70. doi:https://doi.org/10.1016/j.redox.2014.08.002
- Champ CE, Volek JS, Siglin J, Jin L, Simone NL. Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data? Int J Breast Cancer. 2012;2012:506868. doi:https://doi.org/10.1155/2012/506868
- Kämmerer U, Bartmann C, Wöckel A, Reuss-Borst M. Krebszellen lieben Zucker, Patientinnen brauchen Fett. Gynäkologe. 2019;52(7):519–24. doi:https://doi.org/10.1007/s00129-019-4459-x
- Hyde PN, Lustberg MB, Miller VJ, LaFountain RA, Volek JS. Pleiotropic effects of nutritional ketosis: conceptual framework for keto-adaptation as a breast cancer therapy. Cancer Treat Res Commun. 2017;12:32–9. doi:https://doi.org/10.1016/j.ctarc.2017.06.001
- Champ CE, Palmer JD, Volek JS, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Shi W. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. J Neurooncol. 2014;117(1):125–31. doi:https://doi.org/10.1007/s11060-014-1362-0
- Chang HT, Olson LK, Schwartz KA. Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy. Nutr Metab (Lond). 2013;10(1):47. doi:https://doi.org/10.1186/1743-7075-10-47
- Rieger J, Bähr O, Maurer GD, Hattingen ELKE, Franz KEA, Brucker D, Walenta S, Kämmerer U, Coy JF, Weller M, et al. ERGO: a pilot study of ketogenic diet in recurrent glioblastoma Erratum in/ijo/45/6/2605. International Journal of Oncology. 2014;44(6):1843–52. doi:https://doi.org/10.3892/ijo.2014.2382
- Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–33. doi:https://doi.org/10.1126/science.1160809
- Lv M, Zhu X, Wang H, Wang F, Guan W. Roles of caloric restriction, ketogenic diet and intermittent fasting during initiation, progression and metastasis of cancer in animal models: a systematic review and meta-analysis. PLOS One. 2014;9(12):e115147. doi:https://doi.org/10.1371/journal.pone.0115147
- Hursting SD, Dunlap SM, Ford NA, Hursting MJ, Lashinger LM. Calorie restriction and cancer prevention: a mechanistic perspective. Cancer Metab. 2013;1(1):10–1. doi:https://doi.org/10.1186/2049-3002-1-10
- Klement R, Fink M. Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer. Oncogenesis. 2016;5:e193. doi:https://doi.org/10.1038/oncsis.2016.2
- Lee C, Raffaghello L, Brandhorst S, Safdie FM, Bianchi G, Martin-Montalvo A, Pistoia V, Wei M, Hwang S, Merlino A, et al. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med. 2012;4(124):124ra27: doi:https://doi.org/10.1126/scitranslmed.3003293
- Cahill GF. Starvation in man. Clin Endocrinol Metab. 1976;5(2):397–415. doi:https://doi.org/10.1016/S0300-595X(76)80028-X
- Fearon KC, Borland W, Preston T, Tisdale MJ, Shenkin A, Calman KC. Cancer cachexia: influence of systemic ketosis on substrate levels and nitrogen metabolism. Am J Clin Nutr. 1988;47(1):42–8. doi:https://doi.org/10.1093/ajcn/47.1.42
- Lecheminant JD, Gibson CA, Sullivan DK, Hall S, Washburn R, Vernon MC, Curry C, Stewart E, Westman EC, Donnelly JE. Comparison of a low carbohydrate and low fat diet for weight maintenance in overweight or obese adults enrolled in a clinical weight management program. Nutr J. 2007;6:36. doi:https://doi.org/10.1186/1475-2891-6-36
- Volek JS, Freidenreich DJ, Saenz C, Kunces LJ, Creighton BC, Bartley JM, Davitt PM, Munoz CX, Anderson JM, Maresh CM, et al. Metabolic characteristics of keto-adapted ultra-endurance runners. Metabolism. 2016;65(3):100–10. doi:https://doi.org/10.1016/j.metabol.2015.10.028
- Klement RJ. Fasting, fats, and physics: combining ketogenic and radiation therapy against cancer. Complement Med Res. 2018;25(2):102–13. doi:https://doi.org/10.1159/000484045
- Youm Y-H, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, D’Agostino D, Planavsky N, Lupfer C, Kanneganti TD, et al . The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 2015;21(3):263–9. doi:https://doi.org/10.1038/nm.3804
- Klement RJ, Sweeney RA. Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients. BMC Res Notes. 2016;9:143. doi:https://doi.org/10.1186/s13104-016-1959-9
- Huebner J, Marienfeld S, Abbenhardt C, Ulrich C, Muenstedt K, Micke O, Muecke R, Loeser C. Counseling patients on cancer diets: a review of the literature and recommendations for clinical practice. Anticancer Res. 2014;34(1):39–48.
- Khodabakhshi A, Akbari ME, Mirzaei HR, Mehrad-Majd H, Kalamian M, Davoodi SH. Feasibility, safety, and beneficial effects of MCT-based Ketogenic diet for breast Cancer treatment: a randomized controlled trial study. Nutr Cancer. 2020;72(4):627–34. doi:https://doi.org/10.1080/01635581.2019.1650942
- Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer - Where do we stand? Mol Metab. 2020;33:102–21. doi:https://doi.org/10.1016/j.molmet.2019.06.026
- Klement RJ, Champ CE, Kämmerer U, Koebrunner PS, Krage K, Schäfer G, Weigel M, Sweeney RA. Impact of a ketogenic diet intervention during radiotherapy on body composition: III-final results of the KETOCOMP study for breast cancer patients. Breast Cancer Res. 2020;22(1):94. doi:https://doi.org/10.1186/s13058-020-01331-5
- Kang CM, Yun B, Kim M, Song M, Kim Y-H, Lee SH, Lee H, Lee SM, Lee S-M. Postoperative serum metabolites of patients on a low carbohydrate ketogenic diet after pancreatectomy for pancreatobiliary cancer: a nontargeted metabolomics pilot study. Sci Rep. 2019;9(1):16820. doi:https://doi.org/10.1038/s41598-019-53287-y
- Khodabakhshi A, Akbari ME, Mirzaei HR, Mehrad-Majd H, Kalamian M, et al. Feasibility, Safety, and Beneficial Effects of MCT-Based Ketogenic Diet for Breast Cancer Treatment: a Randomized Controlled Trial Study. Nutr Cancer. 2019;72(4):1–8. doi:https://doi.org/10.1080/01635581.2019.1650942
- Erickson N, Boscheri A, Linke B, Huebner J. Systematic review: isocaloric ketogenic dietary regimes for cancer patients. Med Oncol. 2017;34(5):72. doi:https://doi.org/10.1007/s12032-017-0930-5
- Della Corte C, Carpino G, De Vito R, De Stefanis C, Alisi A, Cianfarani S, Overi D, Mosca A, Stronati L, Cucchiara S, et al. Docosahexanoic acid plus vitamin D treatment improves features of NAFLD in children with serum vitamin D deficiency: results from a single centre trial. PLOS One. 2016;11(12):e0168216. doi:https://doi.org/10.1371/journal.pone.0168216
- Higgins JP. Cochrane handbook for systematic reviews of interventions version 5.0. 1. The Cochrane Collaboration; 2008. http://wwwcochrane-handbookorg.
- Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, et al. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons, 2019.
- Díaz PR, Neira LC, Fischer SG, Teresa Torres MC, Milinarsky AT, Giadrosich VR, Arriagada MM, Arinoviche RS, Casanova DM. Effect of 1,25(OH)2-Vitamin D on bone mass in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2008;30(1):15–9. doi:https://doi.org/10.1097/MPH.0b013e318159a522
- DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials. 1986;7(3):177–88. doi:https://doi.org/10.1016/0197-2456(86)90046-2
- Higgins JP, Thompson SG . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58. doi:https://doi.org/10.1002/sim.1186
- Egger M, Davey-Smith G, Altman D. Systematic reviews in health care: meta-analysis in context. London: John Wiley & Sons; 2008.
- Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34. doi:https://doi.org/10.1136/bmj.315.7109.629
- Khodabakhshi A, Seyfried TN, Kalamian M, Beheshti M, Davoodi SH. Does a ketogenic diet have beneficial effects on quality of life, physical activity or biomarkers in patients with breast cancer: a randomized controlled clinical trial. Nutr J. 2020;19(1):87. doi:https://doi.org/10.1186/s12937-020-00596-y
- Cohen CW, Fontaine KR, Arend RC, Gower BA. A Ketogenic diet is acceptable in women with ovarian and endometrial cancer and has no adverse effects on blood lipids: a randomized, controlled trial. Nutr Cancer. 2020;72(4):584–94. doi:https://doi.org/10.1080/01635581.2019.1645864
- Klement RJ, Schäfer G, Sweeney RA. A ketogenic diet exerts beneficial effects on body composition of cancer patients during radiotherapy: an interim analysis of the KETOCOMP study. J Tradit Complement Med. 2020;10(3):180–7. doi:https://doi.org/10.1016/j.jtcme.2019.03.007
- Freedland SJ, Howard L, Allen J, Smith J, Stout J, Aronson W, Inman BA, Armstrong AJ, George D, Westman E, et al. A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial. Prostate Cancer Prostatic Dis. 2019;22(3):428–37. doi:https://doi.org/10.1038/s41391-019-0126-5
- Martin-McGill KJ, Marson AG, Tudur Smith C, Jenkinson MD. The modified Ketogenic diet in adults with glioblastoma: an evaluation of feasibility and deliverability within the National Health Service. Nutr Cancer. 2018;70(4):643–9. doi:https://doi.org/10.1080/01635581.2018.1460677
- Cohen CW, Fontaine KR, Arend RC, Soleymani T, Gower BA. Favorable effects of a ketogenic diet on physical function, perceived energy, and food cravings in women with ovarian or endometrial cancer: a randomized, controlled trial. Nutrients. 2018;10(9):1187. doi:https://doi.org/10.3390/nu1009
- Thompson HJ, Sedlacek SM, Wolfe P, Paul D, Lakoski SG, Playdon MC, McGinley JN, Matthews SB. Impact of weight loss on plasma leptin and adiponectin in overweight-to-obese post menopausal breast cancer survivors. Nutrients. 2015;7(7):5156–76. doi:https://doi.org/10.3390/nu7075156
- Thompson HJ, Sedlacek SM, Playdon MC, Wolfe P, McGinley JN, Paul D, Lakoski SG. Weight loss interventions for breast cancer survivors: impact of dietary pattern. PLoS One. 2015;10(5):e0127366. doi:https://doi.org/10.1371/journal.pone.0127366
- Krie AK, Bohlen KN, Demuth H, Ageton C, Norfolk D, et al. Weight loss and lipid-lowering efficacy of a low carbohydrate, calorie restricted diet intervention on postmenopausal breast cancer patients. Cancer Res. 2013;73. doi:https://doi.org/10.1158/0008-5472.sabcs13-p4-09-04
- Thompson HJ, Sedlacek SM, Paul D, Wolfe P, McGinley JN, Playdon MC, Daeninck EA, Bartels SN, Wisthoff MR. Effect of dietary patterns differing in carbohydrate and fat content on blood lipid and glucose profiles based on weight-loss success of breast-cancer survivors. Breast Cancer Res. 2012;14(1):1–9. doi:https://doi.org/10.1186/bcr3082
- Koike H, Nitta T, Sekine Y, Furuya Y, Morikawa Y, Matsui H, Shibata Y, Suzuki K. High-fat diet increased Leptin, and the antitumor sensitization effect due to survivin inhibition in simvastatin treatment for renal cancer. Eur Urol Suppl. 2012;11(1):E198–U613. doi:https://doi.org/10.1016/S1569-9056(12)60195-X
- Fine EJ, Segal-Isaacson CJ, Feinman RD, Herszkopf S, Romano MC, Tomuta N, Bontempo AF, Negassa A, Sparano JA. Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. Nutrition. 2012;28(10):1028–35. doi:https://doi.org/10.1016/j.nut.2012.05.001
- Schmidt M, Pfetzer N, Schwab M, Strauss I, Kammerer U. Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: a pilot trial. Nutr Metab (Lond). 2011;8(1):54. doi:https://doi.org/10.1186/1743-7075-8-54
- Thomson CA, Stopeck AT, Bea JW, Cussler E, Nardi E, Frey G, Thompson PA. Changes in body weight and metabolic indexes in overweight breast cancer survivors enrolled in a randomized trial of low-fat vs. reduced carbohydrate diets. Nutr Cancer. 2010;62(8):1142–52. doi:https://doi.org/10.1080/01635581.2010.513803
- Schenk JM, Neuhouser ML, Lin DW, Kristal AR. A dietary intervention to elicit rapid and complex dietary changes for studies investigating the effects of diet on tissues collected during invasive surgical procedures. J Am Diet Assoc. 2009;109(3):459–63. doi:https://doi.org/10.1016/j.jada.2008.11.026
- Lin DW, Neuhouser ML, Schenk JM, Coleman IM, Hawley S, Gifford D, Hung H, Knudsen BS, Nelson PS, Kristal AR, et al. Low-fat, low-glycemic load diet and gene expression in human prostate epithelium: a feasibility study of using cDNA microarrays to assess the response to dietary intervention in target tissues. Cancer Epidemiol Biomarkers Prev. 2007;16(10):2150–4. doi:https://doi.org/10.1158/1055-9965.EPI-07-0154
- Nebeling LC, Lerner E. Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer. J Am Diet Assoc. 1995;95(6):693–7. doi:https://doi.org/10.1016/S0002-8223(95)00189-1
- Kolonel LN. Lung cancer: another consequence of a high-fat diet? J Natl Cancer Inst. 1993;85(23):1886–7. doi:https://doi.org/10.1093/jnci/85.23.1886
- Langlais CS, Chan JM. Opportunities and challenges for research on low-carbohydrate diets in prostate cancer. Nat Rev Urol. 2020;17(8):437–8. doi:https://doi.org/10.1038/s41585-020-0326-8
- Voss M, Wagner M, von Mettenheim N, Harter PN, Wenger KJ, et al. ERGO2: a prospective, randomized trial of calorie-restricted ketogenic diet and fasting in addition to reirradiation for malignant glioma. Int J Radiat Oncol Biol Phys. 2020;108(4):987–995. doi:https://doi.org/10.1016/j.ijrobp.2020.06.021
- Artzi M, Liberman G, Vaisman N, Bokstein F, Vitinshtein F, Aizenstein O, Ben Bashat D . Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: 1H-MRS study. J Neurooncol. 2017;132(2):267–75. doi:https://doi.org/10.1007/s11060-016-2364-x
- Augustus E, Granderson I, Rocke KD. The impact of a ketogenic dietary intervention on the quality of life of stage II and III cancer patients: a randomized controlled trial in the Caribbean. Nutr Cancer. 2021;73(9):1590–600. doi:https://doi.org/10.1080/01635581.2020.1803930
- Kämmerer U, Klement RJ, Sütterlin M, Reuss-Borst M. Low carb (LCD) and ketogenic (KD) diets increase quality of life, physical performance, body composition and metabolic health of women with breast cancer better than a standard diet (SD). 2021;13(3):1029.
- Rossi-Fanelli F, Franchi F, Mulieri M, Cangiano C, Cascino A, Ceci F, Muscaritoli M, Seminara P, Bonomo L. Effect of energy substrate manipulation on tumour cell proliferation in parenterally fed cancer patients. Clin Nutr. 1991;10(4):228–32. doi:https://doi.org/10.1016/0261-5614(91)90043-c
- Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hütterer E, Isenring E, Kaasa S, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11–48. doi:https://doi.org/10.1016/j.clnu.2016.07.015
- Ryan AM, Power DG, Daly L, Cushen SJ, Ní Bhuachalla Ē, Prado CM. Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later. Proc Nutr Soc. 2016;75(2):199–211. doi:https://doi.org/10.1017/S002966511500419X
- Chung H-Y, Park YK. Rationale, feasibility and acceptability of ketogenic diet for cancer treatment. J Cancer Prev. 2017;22(3):127–34. doi:https://doi.org/10.15430/JCP.2017.22.3.127
- Martin L, Birdsell L, MacDonald N, Reiman T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB, Baracos VE, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. JCO. 2013;31(12):1539–47. doi:https://doi.org/10.1200/JCO.2012.45.2722
- Cohen CW, Fontaine KR, Arend RC, Alvarez RD, Leath Iii CA, Huh WK, Bevis KS, Kim KH, Straughn JM, Gower BA, et al. A ketogenic diet reduces central obesity and serum insulin in women with ovarian or endometrial cancer. J Nutr. 2018;148(8):1253–60. doi:https://doi.org/10.1093/jn/nxy119
- Yancy WS, Jr, Olsen MK, Guyton JR, Bakst RP, Westman EC. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med. 2004;140(10):769–77. doi:https://doi.org/10.7326/0003-4819-140-10-200405180-00006
- Deluche E, Leobon S, Desport JC, Venat-Bouvet L, Usseglio J, Tubiana-Mathieu N. Impact of body composition on outcome in patients with early breast cancer. Support Care Cancer. 2018;26(3):861–8. doi:https://doi.org/10.1007/s00520-017-3902-6
- Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23(7):1370–8. doi:https://doi.org/10.1200/JCO.2005.01.079
- Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML. Weight gain after breast cancer diagnosis and all-cause mortality: systematic review and meta-analysis. JNCIJ. 2015;107(12):djv275. doi:https://doi.org/10.1093/jnci/djv275
- Weber DD, Aminazdeh-Gohari S, Kofler B. Ketogenic diet in cancer therapy. Aging (Albany, NY). 2018;10(2):164–5. doi:https://doi.org/10.18632/aging.101382
- Harvey AE, Lashinger LM, Hursting SD. The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci. 2011;1229:45–52. doi:https://doi.org/10.1111/j.1749-6632.2011.06096.x
- Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000;92(18):1472–89. doi:https://doi.org/10.1093/jnci/92.18.1472
- Poole EM, Tworoger SS, Hankinson SE, Schernhammer ES, Pollak MN, Baer HJ. Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3. Am J Epidemiol. 2011;174(6):642–51. doi:https://doi.org/10.1093/aje/kwr123
- Wright C, Simone NL. Obesity and tumor growth: inflammation, immunity, and the role of a ketogenic diet. Curr Opin Clin Nutr Metab Care. 2016;19(4):294–9. doi:https://doi.org/10.1097/MCO.0000000000000286
- Georgiadis MS, Steinberg SM, Hankins LA, Ihde DC, Johnson BE. Obesity and therapy-related toxicity in patients treated for small-cell lung cancer. J Natl Cancer Inst. 1995;87(5):361–6. doi:https://doi.org/10.1093/jnci/87.5.361
- Arruebo M, Vilaboa N, Sáez-Gutierrez B, Lambea J, Tres A, Valladares M, González-Fernández A. Assessment of the evolution of cancer treatment therapies. Cancers (Basel). 2011;3(3):3279–330. doi:https://doi.org/10.3390/cancers3033279
- İyikesici MS, Slocum AK, Slocum A, Berkarda FB, Kalamian M, Seyfried TN. Efficacy of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy for stage IV triple-negative breast cancer. Cureus. 2017;9(7):e1445. doi:https://doi.org/10.7759/cureus.1445
- Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab (Lond). 2007;4:5–15. doi:https://doi.org/10.1186/1743-7075-4-5
- Freedland SJ, Mavropoulos J, Wang A, Darshan M, Demark-Wahnefried W, Aronson WJ, Cohen P, Hwang D, Peterson B, Fields T, et al . Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate. 2008;68(1):11–9. doi:https://doi.org/10.1002/pros.20683
- Tan-Shalaby JL, Carrick J, Edinger K, Genovese D, Liman AD, Passero VA, Shah RB. Modified Atkins diet in advanced malignancies-final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System. Nutr Metab (Lond). 2016;13(1):1–12. doi:https://doi.org/10.1186/s12986-016-0113-y
- Stafford P, Abdelwahab MG, Kim DY, Preul MC, Rho JM, Scheck AC. The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. Nutr Metab (Lond). 2010;7(1):1–11. doi:https://doi.org/10.1186/1743-7075-7-74
- Scheck AC, Abdelwahab MG, Fenton KE, Stafford P. The ketogenic diet for the treatment of glioma: insights from genetic profiling. Epilepsy Res. 2012;100(3):327–37. doi:https://doi.org/10.1016/j.eplepsyres.2011.09.022
- Jarrett SG, Milder JB, Liang LP, Patel M. The ketogenic diet increases mitochondrial glutathione levels. J Neurochem. 2008;106(3):1044–51. doi:https://doi.org/10.1111/j.1471-4159.2008.05460.x
- Milder JB, Liang L-P, Patel M. Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet. Neurobiol Dis. 2010;40(1):238–44. doi:https://doi.org/10.1016/j.nbd.2010.05.030
- Aminzadeh-Gohari S, Feichtinger RG, Vidali S, Locker F, Rutherford T, O’Donnel M, Stöger-Kleiber A, Mayr JA, Sperl W, Kofler B. A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model. Oncotarget. 2017;8(39):64728–44. doi:https://doi.org/10.18632/oncotarget.20041
- Allen BG, Bhatia SK, Buatti JM, Brandt KE, Lindholm KE, Button AM, Szweda LI, Smith BJ, Spitz DR, Fath MA. Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts. Clin Cancer Res. 2013;19(14):3905–13. doi:https://doi.org/10.1158/1078-0432.CCR-12-0287
- Hopkins BD, Pauli C, Du X, Wang DG, Li X, Wu D, Amadiume SC, Goncalves MD, Hodakoski C, Lundquist MR, et al. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature. 2018;560(7719):499–503. doi:https://doi.org/10.1038/s41586-018-0343-4
- Zhuang Y, Chan DK, Haugrud AB, Miskimins WK. Mechanisms by which low glucose enhances the cytotoxicity of metformin to cancer cells both in vitro and in vivo. PLOS One. 2014;9(9):e108444. doi:https://doi.org/10.1371/journal.pone.0108444